XProteome is an innovative company focused on revolutionizing plasma protein analysis through advanced nanomedicine and proprietary depletion technologies. By addressing the challenges of detecting low-abundance and rare proteins, XProteome aims to provide comprehensive and accurate protein profiling for early disease detection, personalized medicine, and enhanced research capabilities. Our current technology surpases the state-of-the-art capabilities that are commercialized and currently in use. Leveraging exclusive licensing of global patents, and a team with expertise in proteomics and nanomedicine, XProteome is positioned to penetrate the existing plasma protein analysis market and achieve significant market share by 2030.
Biomarker and target discovery in plasma, and other biological fluids
Tailored solutions for protein depletion in plasma and biological fluids
Secretome analysis in human cells, spheroids and other types of material
XProteome provides proprietary solutions for depletion of abundant proteins in plasma and other biological fluids
Unlock the full potential of your clinical samples with XProteome Inc. solutions and services.
With our tech, …
